Pan-tissue mitochondrial phenotyping reveals lower OXPHOS expression and function across cancer types

Area of Science:

• Mitochondrial biology
• Cancer bioenergetics
• Metabolic pathways in cancer

Background:

• Targeting cancer cell metabolism is a promising therapeutic strategy.
• Mitochondrial oxidative phosphorylation (OXPHOS) is crucial for cellular energy production.
• Challenges exist in selectively targeting cancer mitochondria due to similarities with normal cells.

Purpose of the Study:

• To comprehensively phenotype mitochondrial OXPHOS composition and function across diverse murine cancer types.
• To compare cancer mitochondrial OXPHOS with matched normal tissues and highly oxidative organs.
• To evaluate the potential of OXPHOS as a therapeutic target in cancer treatment.

Main Methods:

• Mitochondrial phenotyping across various murine cancer models.
• Comparative analysis of OXPHOS complex expression and function.
• Assessment of substrate-specific mitochondrial flux.

Main Results:

• Mitochondrial OXPHOS expression and flux are consistently lower in multiple cancer types compared to matched normal tissues and the heart.
• These findings suggest that non-selective OXPHOS inhibitors may impact healthy organs before affecting tumors.
• Significant heterogeneity in mitochondrial proteome composition and substrate-specific flux was observed among different cancer types.

Conclusions:

• Indiscriminate targeting of mitochondrial OXPHOS for cancer therapy may lead to severe side effects in healthy tissues.
• The observed heterogeneity in cancer mitochondrial metabolism suggests potential for developing targeted therapies.
• Further research into cancer-specific mitochondrial pathways is warranted for effective and safe cancer treatment.